Schroder Investment Management Group’s Dyne Therapeutics DYN Stock Holding History

Schroder Investment Management Group’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-386,953	Closed	-$7.43M	–	1205
2025 Q4	$7.43M	Buy	386,953 +111,357	+40%	+$2.11M	0.01%	687
2025 Q3	$3.41M	Buy	275,596 +69,970	+34%	+$798K	﹤0.01%	835
2025 Q2	$1.96M	Sell	205,626 -37,199	-15%	-$410K	﹤0.01%	913
2025 Q1	$2.78M	Buy	242,825 +95,823	+65%	+$1.37M	﹤0.01%	863
2024 Q4	$3.48M	Buy	147,002 +56,961	+63%	+$1.68M	﹤0.01%	839
2024 Q3	$3.05M	Sell	90,041 -52,262	-37%	-$2.08M	﹤0.01%	883
2024 Q2	$5.02M	Buy	142,303 +4,552	+3%	+$132K	0.01%	782
2024 Q1	$3.91M	Hold	137,751	–	–	﹤0.01%	822
2023 Q4	$1.83M	Buy	+137,751	New	+$1.35M	﹤0.01%	923

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Schroder Investment Management Group's DYN Position: Q1 2026 in Review

Schroder Investment Management Group sold out of Dyne Therapeutics (DYN) in Q1 2026, closing a stake of 386,953 shares — an estimated $7.43M sold.

Schroder Investment Management Group first reported a position in DYN in Q4 2023 and held it in 9 quarters. The position peaked at $7.43M in Q4 2025. 228 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

Schroder Investment Management Group reported no remaining Dyne Therapeutics position as of Q1 2026 after selling out during the quarter.
Schroder Investment Management Group sold 386,953 Dyne Therapeutics shares in Q1 2026, an estimated $7.43M.
Schroder Investment Management Group first reported a position in Dyne Therapeutics in Q4 2023 and held it in 9 quarters.
Schroder Investment Management Group's Dyne Therapeutics position peaked at $7.43M in Q4 2025.
228 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.